Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.

Winer, Arthur; Ghatalia, Pooja; Bubes, Nicole; Anari, Fern; Varshavsky, Asya; Kasireddy, Vineela; Liu, Yang; El-Deiry, Wafik S

Winer, Arthur; Ghatalia, Pooja; Bubes, Nicole; Anari, Fern; Varshavsky, Asya; Kasireddy, Vineela; Liu, Yang; El-Deiry, Wafik S.

Afiliación

Winer A; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Ghatalia P; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Bubes N; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Anari F; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Varshavsky A; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Kasireddy V; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Liu Y; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
El-Deiry WS; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA wafik@brown.edu.

Oncologist ; 24(11): 1416-1419, 2019 11.

Article en En | MEDLINE | ID: mdl-31444293

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Antígeno B7-H1/antagonistas & inhibidores; Neoplasias del Colon/tratamiento farmacológico; Neoplasias Colorrectales Hereditarias sin Poliposis/tratamiento farmacológico; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Neoplasias Urológicas/tratamiento farmacológico; Anticuerpos Monoclonales Humanizados/administración & dosificación; Neoplasias del Colon/complicaciones; Neoplasias del Colon/secundario; Neoplasias Colorrectales Hereditarias sin Poliposis/complicaciones; Neoplasias Colorrectales Hereditarias sin Poliposis/patología; Humanos; Ipilimumab/administración & dosificación; Masculino; Persona de Mediana Edad; Nivolumab/administración & dosificación; Pronóstico; Neoplasias Urológicas/complicaciones; Neoplasias Urológicas/patología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Colorrectales Hereditarias sin Poliposis / Neoplasias Urológicas / Neoplasias del Colon / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google